Fisher & Paykel Healthcare announced today that it has filed a patent infringement proceeding in the Federal Court of Australia against ResMed Ltd and several of its related companies.
Fisher & Paykel Healthcare and ResMed are currently engaged in patent proceedings in multiple countries. In the additional proceeding filed today, Fisher & Paykel Healthcare alleges that ResMed’s AirSense 10, AirCurve 10, S9 and S9 VPAP flow generators, Lumis non-invasive ventilators, ClimateLine and ClimateLineAir heated air tubing and HumidAir heated humidifier infringe four patents held by Fisher & Paykel Healthcare. These products are used to treat respiratory conditions. Fisher & Paykel Healthcare is seeking a range of remedies, including damages and injunctions preventing the manufacture and sale of these products by ResMed in Australia.
Lewis Gradon, Managing Director and Chief Executive Officer said, “Over the past 45 years we have made a considerable investment in our research and development programme and built up a significant patent portfolio. We take the infringement of our intellectual property rights very seriously and we will continue to take whatever action is necessary to protect our investment.”
The company advises that the earnings guidance for its 2018 full year results, as provided on 21 November 2017, remains unchanged.
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in over 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.